Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03200028 · ClinicalTrials.gov registry record · NA

CCTAP: Cognitive Control Training for Treatment of AUD-PTSD

A NA study of Alcohol Use Disorder and Post Traumatic Stress Disorder, sponsored by Posit Science Corporation.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03200028 is a NA study of Alcohol Use Disorder and Post Traumatic Stress Disorder that has completed, run by Posit Science Corporation. The registered enrollment target is 9 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03200028, a NA study of Alcohol Use Disorder and Post Traumatic Stress Disorder, has completed, sponsored by Posit Science Corporation.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to evaluate the feasibility of the revised brain training program with individuals diagnosed with Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD).

Interventions

  • OTHER Computerized Plasticity-Based Adaptive Cognitive Training

Study Locations (1)

California

  • Veterans Affairs Palo Alto Health Care System - Palo Alto

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-04-01
Est. Completion 2019-02-28
Phase NA

Sponsor

Posit Science Corporation

30 total trials

What the Registry Record Tells You About NCT03200028

The ClinicalTrials.gov registry entry for NCT03200028 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (97% lower). The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Computerized Plasticity-Based Adaptive Cognitive Training is the first listed.

NCT03200028 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03200028 about?

NCT03200028 is a clinical study titled "CCTAP: Cognitive Control Training for Treatment of AUD-PTSD". The primary objective of this study is to evaluate the feasibility of the revised brain training program with individuals diagnosed with Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD).

What is the current status of trial NCT03200028?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-04-01. Estimated completion is 2019-02-28.

What conditions does trial NCT03200028 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT03200028?

The interventions under investigation include: Computerized Plasticity-Based Adaptive Cognitive Training (OTHER).

Who is sponsoring clinical trial NCT03200028?

This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03200028 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.